Homologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine

A Study to Assess the Safety and Immunogenicity of the Coronavac Vaccine Against COVID-19

NCT04756830 ·Status: UNKNOWN ·Phase: PHASE4

Clinical Trial of Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults

NCT04962308 ·Status: UNKNOWN ·Phase: PHASE4

VLA2001 Booster in Adult Participants After Priming With mRNA COVID-19 Vaccine and/or Natural SARS-CoV-2 Infection

NCT05364242 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

INAVAC Vaccine Phase III (Immunobridging Study) in Healthy Population Aged 12 to 17 Years Old

NCT06282692 ·Status: RECRUITING ·Phase: PHASE3

A Phase III of COVID-19 Vaccine EuCorVac-19 in Healthy Adults Aged 18 Years and Older

NCT05603052 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity Study of Booster Vaccination in Different Doses of COVID-19 Vaccine (Vero Cell),Inactivated for Prevention of COVID-19

NCT05165966 ·Status: COMPLETED ·Phase: PHASE4

Safety and Immunogenicity of COVI-VAC as a Booster Dose in Adults Previously Vaccinated Against COVID-19

NCT05233826 ·Status: COMPLETED ·Phase: PHASE1

Immunogenicity of Heterologous Versus Homologous Prime Boost Schedule With mRNA and Inactivated COVID-19 Vaccines

NCT05668065 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Safety, Tolerability, Reactogenicity, Immunogenicity of Baiya SARS-CoV-2 Vax 2 as a Booster for COVID-19

NCT05873374 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study to Evaluate the Immunogenicity and Safety of A Recombinant Protein COVID-19 Vaccine as Booster Vaccines

NCT05933512 ·Status: UNKNOWN ·Phase: PHASE2

UNAIR Inactivated COVID-19 Vaccine Phase III (Immunobridging Study)

NCT05508477 ·Status: UNKNOWN ·Phase: PHASE3

Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Adults

NCT04911790 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes in an Elderly Population

NCT04983537 ·Status: UNKNOWN ·Phase: PHASE2

A Clinical Trial of Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) in Booster Vaccination

NCT05911048 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Evaluation of the Safety and Immunogenicity of SII Vaccine Constructs Based on the SARS-CoV-2 (COVID-19) Variant in Adults

NCT05029856 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Safety and Immunogenicity of Glycovax-002 Vaccine in Healthy Adults

NCT05799651 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of CoronaVac

NCT05205096 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Platform Trial to Compare Homologous Boost of Authorized COVID-19 Vaccines and Heterologous Boost With UB-612 Vaccine

NCT05293665 ·Status: UNKNOWN ·Phase: PHASE3

A Heterologous 3rd COVID-19 Vaccine of MVC-COV1901 to Evaluate Immunogenicity and Safety in Adults With ChAdOx1-nCov-19

NCT05097053 ·Status: UNKNOWN ·Phase: PHASE4

Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Study

NCT05096832 ·Status: COMPLETED ·Phase: PHASE3

Booster Study of PTX-COVID19-B in Adults Aged 18 Years and Older

NCT05534048 ·Status: UNKNOWN ·Phase: PHASE3

BBV152/BBV154 Heterologus Prime-Boost Study

NCT05639998 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immunogenicity Study of Booster Vaccination With COVID-19 Vaccine (Vero Cell),Inactivated From Different Manufactures for Prevention of COVID-19

NCT05165732 ·Status: SUSPENDED ·Phase: PHASE4

An Open Comprative Study of the Prophylactic Efficacy and a Non-comparative Study of the Immunogenicity and Safety of the Inactivated Whole-virion Concentrated Purified Coronavirus Vaccine (CoviVac)

NCT05407142 ·Status: UNKNOWN ·Phase: PHASE3

Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals

NCT04456595 ·Status: COMPLETED ·Phase: PHASE3